Cleveland HeartLab LLC Announces Speakers for its Fourth Annual Symposium on Cardiovascular Disease, Preventive Medicine

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Cleveland HeartLab Inc. (CHL), a rapidly growing specialty clinical laboratory and cardiovascular disease management company, today announced that its fourth annual symposium, Where Inflammation Meets Lipids®, will focus on unique models and strategies for assessing, treating and preventing chronic disease.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC